No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 3, 2004, Pages 497-498

  Li, Li ^a   Cicek, Mine S ^b   Casey, Graham ^b   Witte, John S ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTOSINE; DINUCLEOTIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; EPITHELIUM CELL; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RISK ASSESSMENT; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; CASE CONTROL STUDY; DINUCLEOTIDE REPEAT; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR;

ADULT; AGED; CASE-CONTROL STUDIES; DINUCLEOTIDE REPEATS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 2442679361     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Yu H, Rohan T. Role of the insulin-like growth family in cancer development and progression. J Natl Cancer Inst, 2000;92:1472-89.
2. Harrela M, Koitinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest, 1996;98:2612-5.
3. Weber JL, May PE. Abundant class of human polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet, 1989;44:188-96.
4. Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE, et al. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer, 2002;100:332-6.
5. Deal C, Ma J, Wilkin F, Paquette J, Rozen F, Ge B, et al. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab, 2001;86:1274-80.
6. Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS. CYP3A4 and CYP3A5 genotypes, haplotypes and risk of prostate cancer. Cancer Epidemiol Biomarkers & Prev, 2003;12:928-32.